K+S Stock Forecast for 2023 - 2025 - 2030

Updated on 04/19/2024

Stock Rating
8
Price Target
15.90€
Consensus
Neutral
Upside
13.65%
Analysts
8
Stock Rating
8
Upside
13.65%
Analysts
8
Price Target
15.90€

K+S Stock Forecast and Price Target

If the average 2024 price target of 15.90€ recently set by eight prominent experts for K+S is met, there would be a potential upside of approximately 13.65% from the last closing price in April, 2024. The high estimate is 20.00€, and the low is 10.00€. If you're considering investing in SDF stock, it's important to look at its competitors too.

15.90€

13.65% Upside

Hold
Hold

K+S Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, K+S's Price has seen an increase, rising from 0.00€ to 0.00€. This represents a growth of 100.00%. Analysts predict that K+S's Fair Value will increase in the upcoming year, reaching 14.75€. This would represent an increase of 100.00%. Over the next seven years, experts predict that K+S's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
14.75€
2025 Fair Value Forecast
14.45€
2026 Fair Value Forecast
23.94€
2027 Fair Value Forecast
26.13€
2028 Fair Value Forecast
27.74€
2029 Fair Value Forecast
30.08€
2030 Fair Value Forecast
32.56€
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
JNJ Stock Forecast Johnson & Johnson Outperform 9
$147.91 Buy/Sell $174.55 14.93%
MRK Stock Forecast Merck Outperform 2
$125.78 Buy/Sell $130.51 10.91%
AZN Stock Forecast AstraZeneca PLC Outperform 17
£109.46 Buy/Sell £165.99 47.83%
TMO Stock Forecast Thermo Fisher Scientific Outperform 10
$544.78 Buy/Sell $591.94 11.33%
NOVN Stock Forecast Novartis Hold 10
CHF85.53 Buy/Sell CHF105.00 23.11%

K+S Revenue Forecast for 2023 - 2025 - 2030

In the last two years, K+S's Revenue has seen an increase, rising from 2.43€B to 5.68€B. This represents a growth of 133.40%. In the next year, 16 analysts estimate that K+S's Revenue will decrease by 34.82%, reaching 3.70€B. According to professional forecasts, in 2030, K+S's Revenue will decrease by 27.13%, reaching 4.14€B.

2024 Rev Forecast
3.70€B
2025 Rev Forecast
3.73€B
2026 Rev Forecast
3.83€B
2027 Rev Forecast
3.89€B
2028 Rev Forecast
3.97€B
2029 Rev Forecast
4.05€B
2030 Rev Forecast
4.14€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BHP Stock Forecast BHP Group Outperform 1
$44.63 Buy/Sell $30.06 -31.75%
PFE Stock Forecast Pfizer Outperform 2
$26.00 Buy/Sell $32.87 17.31%
AMGN Stock Forecast Amgen Outperform 4
$268.93 Buy/Sell $303.65 17.97%

K+S Dividend per Share Forecast for 2023 - 2025 - 2030

K+S's Dividend per Share has seen growth In the last year, going from 0.20€ to 1.00€ – a gain of 400.00% According to 14 analysts, K+S's Dividend per Share will fall by 45.00% in the next year, reaching 0.55€. Professionals believe that By 2030, K+S's Dividend per Share will fall to 0.40€ – a 59.93% decrease from its current value.

2024 DPS Forecast
0.55€
2025 DPS Forecast
0.62€
2026 DPS Forecast
0.10€
2027 DPS Forecast
0.10€
2028 DPS Forecast
0.27€
2029 DPS Forecast
0.68€
2030 DPS Forecast
0.40€
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BMY Stock Forecast Bristol-Myers Squibb Hold 2
$48.93 Buy/Sell $58.15 12.41%
GILD Stock Forecast Gilead Sciences Inc Outperform 11
$66.76 Buy/Sell $87.82 22.83%
GSK Stock Forecast GSK Outperform 12
£15.99 Buy/Sell £17.30 21.95%

K+S Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
0.23€B
2025 FCF Forecast
0.18€B
2026 FCF Forecast
0.29€B
2027 FCF Forecast
0.29€B
2028 FCF Forecast
0.31€B
2029 FCF Forecast
0.32€B
2030 FCF Forecast
0.33€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
8031 Stock Forecast Mitsui & Outperform 3
¥7.13k Buy/Sell ¥6.06k -0.07%
VALE3 Stock Forecast Vale Outperform 5
R$63.36 Buy/Sell R$19.16 -75.05%
LONN Stock Forecast Lonza Group Buy 16
CHF502.80 Buy/Sell CHF516.89 16.35%

K+S EBITDA Forecast for 2023 - 2025 - 2030

K+S's EBITDA has grown in the last two years, jumping from -1.62€B to 2.45€B – an increase of 251.76%. 16 analysts predict K+S's EBITDA will decrease by 71.08% in the next year, reaching 709.40€M. By 2030, professionals predict that K+S's EBITDA will decrease by 58.21%, to 1.03€B.

2024 EBITDA Forecast
0.71€B
2025 EBITDA Forecast
0.71€B
2026 EBITDA Forecast
0.88€B
2027 EBITDA Forecast
0.92€B
2028 EBITDA Forecast
0.95€B
2029 EBITDA Forecast
0.99€B
2030 EBITDA Forecast
1.03€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
DD Stock Forecast DuPont de Nemours Outperform 17
$73.89 Buy/Sell $75.38 8.27%
DSFIR Stock Forecast DSM-Firmenich Outperform 18
104.10€ Buy/Sell 114.60€ 15.27%
NTR Stock Forecast Nutrien Outperform 16
C$72.56 Buy/Sell C$66.09 -20.88%

K+S EBIT Forecast for 2023 - 2025 - 2030

In the last two years, K+S's EBIT has increased by 206.72%, going from -1.92€B to 2.05€B. For the following year, the 11 analysts predict that K+S's EBIT will drop by 86.13%, reaching 284.40€M. In 2030, the professionals' prediction is that SDF's EBIT will decrease by 76.47%, reaching 482.70€M.

2024 EBIT Forecast
0.28€B
2025 EBIT Forecast
0.29€B
2026 EBIT Forecast
0.30€B
2027 EBIT Forecast
0.33€B
2028 EBIT Forecast
0.46€B
2029 EBIT Forecast
0.47€B
2030 EBIT Forecast
0.48€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
SY1 Stock Forecast Symrise Outperform 18
105.40€ Buy/Sell 106.97€ 7.21%
CF Stock Forecast CF Industries Holdings Hold 3
$79.47 Buy/Sell $86.20 6.96%
SQM Stock Forecast Sociedad Química y Minera de ... Outperform 17
$44.99 Buy/Sell $74.26 55.59%

K+S EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, K+S's EPS has seen an increase, rising from -9.42€ to 0.00€. This represents a growth of 100.00%. Analysts predict that K+S's EPS will increase in the upcoming year, reaching 1.01€. This would represent an increase of 100.00%. Over the next seven years, experts predict that K+S's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
1.01€
2025 EPS Forecast
0.99€
2026 EPS Forecast
1.64€
2027 EPS Forecast
1.79€
2028 EPS Forecast
1.90€
2029 EPS Forecast
2.06€
2030 EPS Forecast
2.23€
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
AKZA Stock Forecast Akzo Nobel N.V. Outperform 18
66.28€ Buy/Sell 79.42€ 16.93%
500124 Stock Forecast Dr. Reddy's Laboratories Hold 18
Rp5.94k Buy/Sell Rp5.67k 1.81%
PHOR Stock Forecast Public Joint-Stock Company Pho... - 16
руб7.93k Buy/Sell руб74.28 -69.68%